This HND piece goes into the sordid tale of how a mediocre antiviral got stockpiled to the tune of billions of dollars, during the past flu scares. What's more, it was added to, and then removed from, the WHO Essential Medicines core list.
Credit the BMJ for keeping up the pressure to get the facts out. The only trouble is that it took several years to persuade Roche to come clean with its "hidden" clinical trials.
Read the complete article.